Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImSonic is a South Korean medical technology company specializing in the design and manufacture of advanced ultrasound transducers and therapeutic ultrasound components. Established in 2001, the company provides a comprehensive portfolio of diagnostic probes, including linear, convex, and phased array transducers, as well as High-Intensity Focused Ultrasound (HIFU) technology for medical and aesthetic applications. ImSonic operates as a key OEM partner for global medical device manufacturers, offering customized acoustic solutions based on proprietary piezoelectric materials. Their products are utilized across various clinical fields, including radiology, cardiology, and minimally invasive surgery. The company is recognized for its expertise in high-frequency ultrasound and its ability to develop specialized transducers for intravascular and endoscopic applications. With a focus on innovation and quality, ImSonic maintains ISO 13485 certification and serves a diverse international healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImSonic Medical.